Evaluation of angiogenesis in colorectal carcinoma with multidetector-row CT multislice perfusion imaging

被引:18
作者
Feng, Shi-Ting [1 ]
Sun, Can-Hui [1 ]
Li, Zi-Ping [1 ]
Mak, Henry Ka-Fung [2 ]
Peng, Zhen-Peng [1 ]
Guo, Huan-Yi [1 ]
Meng, Quan-Fei [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510080, Guangdong, Peoples R China
[2] Univ Hong Kong, Dept Diagnost Radiol, Hong Kong, Hong Kong, Peoples R China
关键词
Colorectal neoplasm; Microvessel density; Vascular endothelial growth factor; Perfusion; Tomography; X-ray computed; ENDOTHELIAL GROWTH-FACTOR; DYNAMIC COMPUTED-TOMOGRAPHY; TUMOR ANGIOGENESIS; MICROVESSEL DENSITY; PROGNOSTIC-FACTOR; CANCER; SURVIVAL; METASTASIS; EXPRESSION;
D O I
10.1016/j.ejrad.2009.04.058
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
100231 [临床病理学]; 100902 [航空航天医学];
摘要
To evaluate the correlation between 64 multidetector-row CT (64MDCT) perfusion imaging in colorectal carcinoma and microvessel density (MVD) and vascular endothelial growth factor (VEGF), 64MDCT perfusion imaging was performed in 33 patients with pathologically verified colorectal carcinoma. These images were analyzed with perfusion functional software, and time-density curves (TDC) were created for the region of interest (ROI) encompassing the tumor, the target artery and vein. The individual perfusion maps generated indicated blood flow (BF), blood volume (BV), mean transit time (MTT), and permeability-surface area product (PS). MVD and VEGF were evaluated by immunohistochemical staining with anti-CD34 and anti-VEGF, respectively. Correlations between MVD or VEGF with CT perfusion parameters and clinicopathological factors (Dukes' stages, invasion depth, and lymph node and liver metastasis) were also investigated. MVD in the colorectal carcinoma was 22.61 +/- 9.01 per x 200 field. The scores obtained for VEGF expression were 4.15 +/- 1.09. VEGF staining was positive in 25 of 29 tumors (86.2%). There was no significant correlation between the presence of MVD, VEGF expression and clinicopathological factors (P > 0.05). There was also no correlation between MVD, VEGF expression, and any dynamic CT parameters (P > 0.05). The BV and MTT were significantly higher in tumors demonstrating serous coat invasion than in those without it (t = -2.63,-2.24, P = 0.0137, 0.0331, respectively). BV was also significantly correlated with tumor size (r = 0.41, P = 0.02). Neither BF nor PS was correlated with clinicopathological factors. In conclusion, 64MDCT perfusion imaging, MVD, and VEGF may reflect angiogenic activity, but no significant correlation among these factors. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:191 / 196
页数:6
相关论文
共 20 条
[1]
CEREBRAL BLOOD-VOLUME MAPS OF GLIOMAS - COMPARISON WITH TUMOR GRADE AND HISTOLOGIC-FINDINGS [J].
ARONEN, HJ ;
GAZIT, IE ;
LOUIS, DN ;
BUCHBINDER, BR ;
PARDO, FS ;
WEISSKOFF, RM ;
HARSH, GR ;
COSGROVE, GR ;
HALPERN, EF ;
HOCHBERG, FH ;
ROSEN, BR .
RADIOLOGY, 1994, 191 (01) :41-51
[2]
BOSSI P, 1995, CANCER RES, V55, P5049
[3]
Boucher Y, 1996, CANCER RES, V56, P4264
[4]
Chen CN, 2000, CANCER RES, V60, P2892
[5]
Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma [J].
DeVries, AF ;
Kremser, C ;
Hein, PA ;
Griebel, J ;
Krezcy, A ;
Öfner, D ;
Pfeiffer, KP ;
Lukas, P ;
Judmaier, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (04) :958-965
[6]
Vasculogenic mimicry and tumor angiogenesis [J].
Folberg, R ;
Hendrix, MJC ;
Maniotis, AJ .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (02) :361-381
[7]
Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma [J].
Furudoi, A ;
Tanaka, S ;
Haruma, K ;
Kitadai, Y ;
Yoshihara, M ;
Chayama, K ;
Shimamoto, F .
ONCOLOGY, 2002, 62 (02) :157-166
[8]
Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer [J].
George, ML ;
Dzik-Jurasz, ASK ;
Padhani, AR ;
Brown, G ;
Tait, DM ;
Eccles, SA ;
Swift, RI .
BRITISH JOURNAL OF SURGERY, 2001, 88 (12) :1628-1636
[9]
Hansen S, 1998, LAB INVEST, V78, P1563
[10]
Hawighorst H, 1998, CANCER RES, V58, P3598